Digest Network Come funziona
Network
/
Società
Go
Non verificato

Gossamer Bio, Inc.

Di cosa scriviamo

BiotecnologiaCardiologiaFarmaceuticaMedicina - VarieSalute

27 comunicati stampa

Guarda tutti i comunicati
24/11/2025
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Eventi
Gossamer Bio to Participate in Upcoming Investor Conferences
Fonte
Gossamer Bio, Inc.
Emittente
Business Wire
1.00
0
07/11/2025
Biotecnologia
Sanità
Salute
Farmaceutica
Cardiologia
Mercato azionario
Finanza
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Fonte
Gossamer Bio, Inc.
Emittente
Business Wire
1.00
0
07/11/2025
Biotecnologia
Salute
Scienza
Farmaceutica
Eventi
Web e Social Network
Gossamer Bio to Participate in Upcoming Investor Conferences
Fonte
Gossamer Bio, Inc.
Emittente
Business Wire
1.00
0
05/11/2025
Mercato azionario
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Gossamer Bio Announces Third Quarter 2025 Financial Results and Provides Business Update
Fonte
Gossamer Bio, Inc.
Emittente
Business Wire
1.00
0
25/09/2025
Industria
Salute
Medicina - Varie
Sanità
Farmaceutica
Cardiologia
Biotecnologia
Gossamer Bio Enters into Option Agreement to Acquire Respira Therapeutics and Its Lead Candidate, RT234, an Inhaled, On‑Demand Vardenafil for Pulmonary Hypertension
Fonte
Gossamer Bio, Inc.
Emittente
Business Wire
1.00
0
22/09/2025
Eventi
Salute
Biotecnologia
Scienza
Farmaceutica
Cardiologia
Gossamer Bio Announces Presentations at the European Respiratory Society (ERS) Congress 2025
Fonte
Gossamer Bio, Inc.
Emittente
Business Wire
1.00
0
29/08/2025
Biotecnologia
Farmaceutica
Salute
Cardiologia
Web e Social Network
Eventi
Industria
Gossamer Bio to Present at Upcoming Investor Conferences
Fonte
Gossamer Bio, Inc.
Emittente
Business Wire
1.00
0
07/08/2025
Salute
Medicina - Varie
Scienza
Farmaceutica
Cardiologia
Biotecnologia
Mercato azionario
Finanza
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Fonte
Gossamer Bio, Inc.
Emittente
Business Wire
1.00
0
05/08/2025
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Mercato azionario
Gossamer Bio Announces Second Quarter 2025 Financial Results and Provides Business Update
Fonte
Gossamer Bio, Inc.
Emittente
Business Wire
1.00
0
16/06/2025
Salute
Medicina - Varie
Scienza
Farmaceutica
Cardiologia
Biotecnologia
Industria
Gossamer Bio Announces Completion of Enrollment in Registrational Phase 3 PROSERA Study for the Treatment of PAH
Fonte
Gossamer Bio, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0